1.1 Articolo su rivista

1.1 Articolo su rivista: [72033] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 4.241 a 4.260 di 72.033

Radiative Chemically MHD Non-Newtonian Nanofluid Flow over an Inclined Stretching Sheet with Heat Source and Multi-Slip Effects

2024-01-01 Kumari, Pennelli Saila; Ibrahim, Shaik Mohammed; Kumar, Prathi Vijaya; Lorenzini, Giulio

An Effect of Mass Transpiration and Darcy–Brinkman Model on Ostwald–de Waele Ternary Nanofluid

2024-01-01 Mahabaleshwar, U. S.; Sachhin, S. M.; Pérez, L. M.; Lorenzini, G.

The need for inhaled phosphodiesterase inhibitors in chronic obstructive pulmonary disease

2024-01-01 Cazzola, M.; Calzetta, L.; Rogliani, P.; Matera, M. G.

Interaction between fluticasone furoate and umeclidinium in passively sensitized isolated human airways

2024-01-01 Matera, M. G.; Calzetta, L.; Rinaldi, B.; Belardo, C.; Facciolo, F.; Gallina, F. T.; Page, C. P.; Cazzola, M.; Rogliani, P.

Real-World Efficacy of Biological Therapies in Severe Asthma: A Focus on Small Airways

2024-01-01 Ora, J.; De Marco, P.; Motta, E.; Laitano, R.; Calzetta, L.; Rogliani, P.

Inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review and meta-analysis on mortality protection - making a long story short

2025-01-01 Rogliani, P.; Manzetti, G. M.; Gholamalishahi, S.; Bafadhel, M.; Calzetta, L.

Reducing the risk of death–a possible outcome in COPD patients

2024-01-01 Maniscalco, M.; Calzetta, L.; Rogliani, P.; Cazzola, M.

Ensifentrine approval: A milestone in the treatment of COPD

2024-01-01 Calzetta, L.; Rogliani, P.

Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences

2024-01-01 Cazzola, M.; Page, C. P.; Hanania, N. A.; Calzetta, L.; Matera, M. G.; Rogliani, P.

Erratum: Expression of concern regarding the article titled “Variability in the serum and tissue concentrations of pre-incisional ceftriaxone for surgery in paediatric population and outcome of surgical-site infections; An open labelled, prospective, non-randomized, analytical study” (Current Research in Pharmacology and Drug Discovery (2022) 3, (S2590257122000025), (10.1016/j.crphar.2022.100082))

2025-01-01 Calzetta, L.

Animal models of chronic obstructive pulmonary disease and their role in drug discovery and development: a critical review

2025-01-01 Matera, M. G.; Calzetta, L.; Rinaldi, B.; De Novellis, V.; Page, C. P.; Barnes, P. J.; Cazzola, M.

Characterisation of the novel quinoline RCD405: Relaxant effects on cholinergic and histaminergic tone in human bronchi and small airways

2025-01-01 Rogliani, P.; Page, C.; Facciolo, F.; Lundblad, M.; Calzetta, L.

Corrigendum to “Clinical efficacy of inhaled corticosteroids in equine asthma: A meta-analysis and number needed to treat” [Pulm. Pharmacol. Therapeut. (88), March 2025, 102342] (Pulmonary Pharmacology & Therapeutics (2025) 88, (S1094553924000580), (10.1016/j.pupt.2024.102342))

2025-01-01 Pistocchini, E.; Carrillo Heredero, A. M.; Mazan, M.; Couetil, L.; Bertini, S.; Calzetta, L.

Impact of Airway-Occluding Mucus Plugs on Mortality in Patients with COPD According to Disease Severity: A Subset Analysis of Data From COPDGene

2025-01-01 Rogliani, P.; Calzetta, L.

Dose of Inhaled Corticosteroids and Cardiovascular Disease in Asthma: An Unexpected Misstep?

2025-01-01 Rogliani, P.; Calzetta, L.

Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/ Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-Analysis

2025-01-01 Rogliani, P.; Manzetti, G. M.; Cazzola, M.; Calzetta, L.

Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application

2024-01-01 Calzetta, L.; Page, C.; Matera, M.; Cazzola, M.; Rogliani, P.

PI3K Inhibitors as Potential Therapeutic Agents for the Treatment of COPD with Associated Atherosclerosis

2025-01-01 Cazzola, M.; Page, C.; Rogliani, P.; Calzetta, L.; Matera, M. G.

Cardiovascular Events in Chronic Obstructive Pulmonary Disease: Squeezing ETHOS Dry for Clinical Evidence at Risk of Type I Error

2025-01-01 Calzetta, L.; Rogliani, P.

Challenges in treating patients with comorbid asthma and bronchiectasis

2025-01-01 Cazzola, M.; Calzetta, L.; Matera, M. G.; Rogliani, P.; Patella, V.

Titolo	Data di pubblicazione	Autore(i)
Radiative Chemically MHD Non-Newtonian Nanofluid Flow over an Inclined Stretching Sheet with Heat Source and Multi-Slip Effects	1-gen-2024	Kumari, Pennelli Saila; Ibrahim, Shaik Mohammed; Kumar, Prathi Vijaya; Lorenzini, Giulio
An Effect of Mass Transpiration and Darcy–Brinkman Model on Ostwald–de Waele Ternary Nanofluid	1-gen-2024	Mahabaleshwar, U. S.; Sachhin, S. M.; Pérez, L. M.; Lorenzini, G.
The need for inhaled phosphodiesterase inhibitors in chronic obstructive pulmonary disease	1-gen-2024	Cazzola, M.; Calzetta, L.; Rogliani, P.; Matera, M. G.
Interaction between fluticasone furoate and umeclidinium in passively sensitized isolated human airways	1-gen-2024	Matera, M. G.; Calzetta, L.; Rinaldi, B.; Belardo, C.; Facciolo, F.; Gallina, F. T.; Page, C. P.; Cazzola, M.; Rogliani, P.
Real-World Efficacy of Biological Therapies in Severe Asthma: A Focus on Small Airways	1-gen-2024	Ora, J.; De Marco, P.; Motta, E.; Laitano, R.; Calzetta, L.; Rogliani, P.
Inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review and meta-analysis on mortality protection - making a long story short	1-gen-2025	Rogliani, P.; Manzetti, G. M.; Gholamalishahi, S.; Bafadhel, M.; Calzetta, L.
Reducing the risk of death–a possible outcome in COPD patients	1-gen-2024	Maniscalco, M.; Calzetta, L.; Rogliani, P.; Cazzola, M.
Ensifentrine approval: A milestone in the treatment of COPD	1-gen-2024	Calzetta, L.; Rogliani, P.
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences	1-gen-2024	Cazzola, M.; Page, C. P.; Hanania, N. A.; Calzetta, L.; Matera, M. G.; Rogliani, P.
Erratum: Expression of concern regarding the article titled “Variability in the serum and tissue concentrations of pre-incisional ceftriaxone for surgery in paediatric population and outcome of surgical-site infections; An open labelled, prospective, non-randomized, analytical study” (Current Research in Pharmacology and Drug Discovery (2022) 3, (S2590257122000025), (10.1016/j.crphar.2022.100082))	1-gen-2025	Calzetta, L.
Animal models of chronic obstructive pulmonary disease and their role in drug discovery and development: a critical review	1-gen-2025	Matera, M. G.; Calzetta, L.; Rinaldi, B.; De Novellis, V.; Page, C. P.; Barnes, P. J.; Cazzola, M.
Characterisation of the novel quinoline RCD405: Relaxant effects on cholinergic and histaminergic tone in human bronchi and small airways	1-gen-2025	Rogliani, P.; Page, C.; Facciolo, F.; Lundblad, M.; Calzetta, L.
Corrigendum to “Clinical efficacy of inhaled corticosteroids in equine asthma: A meta-analysis and number needed to treat” [Pulm. Pharmacol. Therapeut. (88), March 2025, 102342] (Pulmonary Pharmacology & Therapeutics (2025) 88, (S1094553924000580), (10.1016/j.pupt.2024.102342))	1-gen-2025	Pistocchini, E.; Carrillo Heredero, A. M.; Mazan, M.; Couetil, L.; Bertini, S.; Calzetta, L.
Impact of Airway-Occluding Mucus Plugs on Mortality in Patients with COPD According to Disease Severity: A Subset Analysis of Data From COPDGene	1-gen-2025	Rogliani, P.; Calzetta, L.
Dose of Inhaled Corticosteroids and Cardiovascular Disease in Asthma: An Unexpected Misstep?	1-gen-2025	Rogliani, P.; Calzetta, L.
Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/ Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-Analysis	1-gen-2025	Rogliani, P.; Manzetti, G. M.; Cazzola, M.; Calzetta, L.
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application	1-gen-2024	Calzetta, L.; Page, C.; Matera, M.; Cazzola, M.; Rogliani, P.
PI3K Inhibitors as Potential Therapeutic Agents for the Treatment of COPD with Associated Atherosclerosis	1-gen-2025	Cazzola, M.; Page, C.; Rogliani, P.; Calzetta, L.; Matera, M. G.
Cardiovascular Events in Chronic Obstructive Pulmonary Disease: Squeezing ETHOS Dry for Clinical Evidence at Risk of Type I Error	1-gen-2025	Calzetta, L.; Rogliani, P.
Challenges in treating patients with comorbid asthma and bronchiectasis	1-gen-2025	Cazzola, M.; Calzetta, L.; Matera, M. G.; Rogliani, P.; Patella, V.

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 4.241 a 4.260 di 72.033

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext58713
reserved8054
open3774
partially open822
restricted667
embargoed2
mixed1